Small FMCG

Cupid Ltd.

CUPID

Market Cap
₹28,682 Cr.
P/E
265.00

Cupid Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
28,682 Cr
PE
PE
265
Prom Holding
Prom Holding
46.03 %
ROE (%)
ROE (%)
11.95
ROCE (%)
ROCE (%)
16.23
Div Yield (%)
Div Yield (%)
-
Sales
Sales
362 Cr
OPM (%)
OPM (%)
33.54 %
Debt to Equity
Debt to Equity
0.05
Institutions
Institutions
1.18 %
Individual < 2 lac
Individual < 2 lac
13.81 %
No. of Shareholders
No. of Shareholders
2.10 L
View more
Edit Ratio's

About

Cupid Limited, a Public Limited Company established in 1993, is a global leader in the manufac… Read more
Low
21
52W Range
High
214
  • Cupid
  • Medplus Health Serv.
  • Jeena Sikho Lifecare

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • Order Book as a % of Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Cupid Ltd. Business

    Cupid Limited is a global manufacturer and supplier of male and female condoms as well as lubricant jelly. It collaborates with various stakeholders to promote sexual health and encourage condom use for HIV and STD prevention.

    Cupid major competitors are Medplus Health Serv., Jeena Sikho Lifecare, Amrutanjan Health., Health X Platform, Max India, Rajnish Wellness, Dr. Lal Pathlabs.
    Market Cap of Cupid is ₹26,745 Crs.
    While the median market cap of its peers are ₹1,552 Crs.

    Cupid seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice

    Company Filing

    Discussions & Analysis

    Cupid Ltd.
    Cupid Limited Valuation: David Vs. Goliath - Dinesh Sairam
    Analysis: Cupid Limited - Dr Vijay Malik
    View the discussion on ValuePickr
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material